The Court of Cassation validates the use of saliva tests without proof of their reliability
Share
A key decision for the legal framework of roadside screenings
On March 12, 2025, the Court of Cassation issued an important ruling clarifying the legal framework for saliva drug screening tests conducted by law enforcement. The ruling (appeal no. 24-82.925) overturns a decision by the Rennes court of appeal that had annulled a procedure on the grounds that the police had not provided precise information on the reliability of the test used.
This decision could have a direct impact on road checks, as well as on debates surrounding prevention and the fight against drug use while driving.
The facts of the case: an acquittal overturned by the Court of Cassation
The case involved a driver stopped in February 2019 by the gendarmes, who conducted a saliva test revealing the presence of drugs. Based on this screening, samples were taken and confirmed the positive result.
Convicted at first instance, the motorist had won on appeal, the court having ruled that the lack of precise information about the test (brand, batch number, expiration date) prevented verification of its reliability.
The Attorney General then filed an appeal to the Court of Cassation, contesting this annulment.
Why did the Court of Cassation overturn the court of appeal’s decision?
The Court of Cassation relied on articles L. 235-1 and L. 235-2 of the highway code to make its decision. According to these texts:
- Saliva screening tests only serve to presume drug use.
- They allow for authorization of a biological sample which can then irrefutably establish the offense.
- Law enforcement is not required to prove the reliability of the saliva test, nor to specify its technical references.
The Court of Cassation therefore ruled that the court of appeal committed a legal error by annulling the procedure on a legally unfounded basis.
Consequence: the decision is overturned and the case will be retried.
What are the consequences for motorists and road safety prevention?
This decision reinforces the legitimacy of saliva tests, which are now indisputable, even if their reliability is not demonstrated on a case-by-case basis. This raises several questions:
-
From a legal perspective
From now on, a positive screening result will be difficult to contest in court, except in cases of obvious procedural error. This strengthens the powers of law enforcement but also potentially reduces the means of defense for drivers. -
Regarding test reliability
Some experts worry that a saliva test can detect traces of substances consumed several days earlier, without necessarily indicating impairment at the time of the test. -
From a prevention perspective
This decision highlights the importance of raising more awareness rather than limiting ourselves to a strictly punitive framework. Indeed, many drivers do not know how long drugs remain detectable in their system, which can expose them to a positive test even if they no longer feel the effects.
Screening and prevention: what balance?
Drug screening while driving is primarily a road safety measure aimed at protecting users. However, its effectiveness also depends on prevention and driver information.
💡 Some key facts to remember:
- Cannabis can be detected up to 24 hours after consumption, or longer in case of regular use.
- Cocaine and amphetamines remain on average 12 to 24 hours in saliva.
- Unlike alcohol, where the effect is directly measurable in mg/L of blood, drug tests do not indicate whether a driver is still under the influence or has simply consumed recently.
A responsible approach to avoid repression
Rather than limiting ourselves to sanctions, it is essential to develop prevention tools:
✔️ Inform about drug detection times
✔️ Encourage self-testing before driving
✔️ Train companies and event organizers in prevention
It is with this in mind that AMA Prévention offers reliable screening tests, as well as awareness solutions to prevent risks before they lead to sanctions.
Conclusion
The ruling of March 12, 2025 marks a turning point in case law on drug screening. It strengthens the punitive framework while raising questions about prevention and driver information.
While screening remains essential to ensure road safety, it is equally crucial to support these measures with appropriate awareness to prevent risky behaviors and reduce offenses rather than just punish them.
We want to hear your opinion!
What do you think of this decision? Should prevention be strengthened? Share your opinion in the comments! 💬🚗
💡 To go further:
📌 Articles L. 235-1 and L. 235-2 of the Highway Code → Legifrance
📌 Full decision of the Court of Cassation → Court of Cassation
About AMA Prévention
A committed player in risk behavior prevention, AMA Prévention supports companies, event organizers, and individuals with screening and awareness solutions.
Find our resources on ama-prevention.fr 🚀
💡 Practical information on screening
During a roadside check, the gendarmerie saliva test is commonly used to detect the presence of drugs. Many wonder about how long the gendarmerie saliva drug test remains positive: it depends on metabolisms, but THC remains detectable for several hours to a few days. The gendarmerie thc saliva test (or gendarmerie saliva thc test) particularly targets recent cannabis consumption.
To carry out prevention at home or in the workplace, performing a thc saliva test (also called saliva thc test) is an excellent approach. If you are looking to equip yourself, you may wonder where to buy saliva test gendarmerie equivalent? Although it can sometimes be difficult to find a thc saliva test pharmacy, you can order our professional devices directly online.
🚨 Road Safety Reminder
Driving under the influence of narcotics is severely punished by law. Anticipate with a reliable self-test before getting behind the wheel.
Scientific validation of B-SAFE
The B-SAFE project, a drug detector pen for drinks, is validated and supported by Professor Jean-Claude Alvarez, toxicologist, professor of pharmacology-toxicology, and director of the toxicology laboratory at CHU Raymond-Poincaré/AP-HP in Garches.
An authority figure in toxicology, he is associated with the reference work conducted in France on psychoactive substances and chemical submission, in a national ecosystem also supported in public debate by voices such as Sandrine Josso and Caroline Darian.
This validation strengthens B-SAFE's technological positioning and the accuracy of its detection for drug prevention in drinks. Discover the B-SAFE product sheet.